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ABSTRACT 
Background: Myogenous pain of the chewing muscles is a subgroup of 
temporomandibular disorder (TMD). It is a complex condition not fully 
understood at this time. One possible causal factor of myogenous TMD may 
be overloading of the jaw joint and muscles as a result of prolonged low-level 
clenching. This includes behaviours such as clenching and grinding, which 
may be observed during awake hours. The use of wireless surface 
electromyography (EMG) allows for the collection of objective data 
regarding jaw muscle activity in the habitual environment.  
Methods: Female patients (N = W], mean age W].^ ± ̀ .Q years) diagnosed with 
myalgia or myofascial pain with referral were age matched with TMD-free 
controls (N = W`, mean age Wa.^yrs ± ̀ .b years). A single examiner completed 
a standardised TMD examination on all participants to confirm eligibility for 
the study. Participants were fitted with a minimally invasive wireless EMG 
sensor on the skin surface overlying the masseter muscle on their preferred 
chewing side. Participants wore the EMG sensors while awake, over two 
consecutive days. Maximum voluntary contraction (MVC) was identified as 
peak bite force. Contraction episodes were detected at four thresholds: Q x 
minimum root mean square (RMS) at rest, Q% MVC, b% MVC, e^% MVC.  
Results: The vast majority of the participants in the patient group had 
myofascial pain affecting the masseter muscles. Maximum opening was 
decreased in the patients compared to controls. The Oral Behaviour 
Checklist (OBC) summary score was higher in patients than controls (p < 
^.^e). MVC was eeWg.] ± bb^.a μV in the patient group and eW^W.b ± gWg.b μV 
in the control group (p = ^.bbi). The frequency, duration and amplitude of 
masseter contraction episodes were calculated. Most masseter contraction 
episodes of both patients and controls were of relatively low amplitude (< 
e^% MVC) and short duration (< e^ seconds). There was no significant 
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difference in the number of episodes per hour between groups. A significant 
difference in total contraction time % was found between groups (p = ^.^Qi) 
with a tendency to longer contractions in the patient group. No significant 
association was found between self-reported parafunction and masticatory 
muscle activity. 
Conclusion: Patients with myogenous TMD reported a higher level of 
parafunction. Patients and controls have a similar level of number of 
contractions during waking hours but the contractions are longer. The OBC 
may not be a reliable tool for assessing wake-time parafunction. 
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THESIS OUTLINE 
 
This research project focuses on the association of masticatory muscle 
activity and muscle-related temporomandibular disorders. For convenience 
of future publications, this study is presented in six chapters in the format of 
a Hybrid Thesis. As such, a degree of overlap between the chapters is 
inevitable. The thesis is organised as follows: 
Chapter : – Review of the Literature 
A general overview of temporomandibular disorders and oral parafunctional 
behaviour is presented in the first chapter. This includes a review of the 
literature on the epidemiology and psychosocial impact of the condition, 
current understanding of the aetiology, and methods of assessment of 
masticatory muscle activity.  
Chapter B – Core Materials and Methods 
The methodological details of the present study are presented in the second 
chapter. The chapter presents an overview of the study design, participant 
recruitment, specialised equipment used, examination procedure and data 
analysis. 
Chapter G – Questionnaire and Clinical Finings in a Sample of 
Females with Myogenous TMD Pain 
The clinical findings of the study are presented in the third chapter along 
with a comparison of self-reported oral behaviours in the patient and control 
groups. 
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Chapter O – Masticatory Muscle Activity in Patients with 
Myogenous TMD Pain 
The electromyographic findings of masticatory muscle activity in patients 
with myogenous TMD-related pain and healthy age-matched controls is 
presented in the fourth chapter.  
Chapter P – Future Research Directions 
The fifth and final chapter of this work summarises the study’s conclusions 
and possible avenues to be investigated in the future. 
Chapter Q – Appendices 
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Temporomandibular disorder (TMD) is a collective term given to a broad 
range of conditions that involve the muscles of mastication, 
temporomandibular joints (TMJ) and the associated bony and soft tissue 
structures (Okeson, eii`; Liu and Steinkeler, W^eQ). Symptoms of TMD 
typically include pain of the masticatory muscles and/or TMJ, altered jaw 
function, pain on chewing, reduced range of movement of the mandible, 
locking and joint noises. In addition to these symptoms, patients may also 
report headaches, dizziness, ear ache or ringing in the ears (Glaros and 
Lausten, W^^Q). The overwhelming majority of patients seeking treatment 
do so for relief of TMD-related pain  (Dworkin et al., eii^).   
1.2 EPIDEMIOLOGY 
TMD is the second most common musculoskeletal condition resulting in 
pain, following chronic lower back pain. The prevalence of TMD reported in 
the literature varies greatly. A systematic review reported a low prevalence 
of TMD signs in the general population with a prevalence of  i.]% for 
masticatory muscle pain, ee.g% for disc displacement disorders, and W.`% for 
arthralgia/osteoarthritis  (Manfredini et al., W^ee). The inconsistency in 
prevalence data is unlikely due to variations in the populations studied and 
more likely due to a lack of homogeneity in the diagnostic criteria applied in 
different investigations prior to the introduction of standardised diagnostic 
criteria (Manfredini et al., W^ee). Moreover, high prevalence values in some 
studies may be attributed to the inclusion of mild signs and symptoms. 
Severe pain and dysfunction are less common (Murray et al., eii`). The 
incidence for first onset TMD is approximately g% (Slade, et al., W^eQa). The 
treatment need in the general population is approximately eb% (Al-Jundi et 
al., W^^a). 
 3 
There are more females than males seeking treatment for TMD with a ratio 
of Q.Q between genders (Manfredini et al., W^ee). This gender distribution is 
consistent with other painful musculoskeletal and non-musculoskeletal 
disorders which also show a female predominance (Gran, W^^Q; Fillingim, 
W^e]). Multiple mechanisms have been proposed to explain these sex 
differences: differences in endogenous opioid function, cognitive/affective 
influences, social factors and the effects of sex hormones (Fillingim W^e]). 
With regard to sex hormones, studies in both animals and humans have 
suggested a sexual dimorphism with an increased number of estrogen and 
progesterone receptors in the articular tissues of females (Milam et al., eia]; 
Abubaker et al., eiiQ). The theory of hormonal influence is supported by the 
age distribution of TMD, with a pattern of onset after puberty and a decrease 
in prevalence following menopause. For instance, signs and symptoms of 
TMD occur equally in younger boys and girls with the gender difference 
becoming apparent after puberty (Magnusson et al., eiab).  Moreover, there 
is a higher risk of painful TMD in patients receiving estrogens or taking oral 
contraceptives (LeResche et al., eii]).  
Longitudinal epidemiologic studies showed the benign nature of TMD: signs 
and symptoms fluctuate over time, may resolve spontaneously and 
progression to a severe condition occurs very rarely (Magnusson et al., eiab; 
Magnusson et al., eiiQ; Könönen et al., eii`; Magnusson et al., W^^^).  
Unlike other chronic joint conditions, the prevalence of TMD decreases in 
elderly patients (Carlsson, eiii), and signs and symptoms of TMD are mild 
(Tzakis et al., eiig).  
1.3 PSYCHOSOCIAL IMPACT OF TMD 
Oral health-related quality of life (OHRQoL) is a well-accepted way of 
describing the impact of a disease condition on perceived oral health. The 
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Oral Health Impact Profile (OHIP) is one of the most widely used OHRQoL 
instruments. A number of studies have assessed the effect of TMD on 
OHRQoL. John et al. (W^^]) found that patients with a diagnosis of TMD, 
regardless of the diagnosis, had a considerably impaired OHRQoL: the mean 
OHIP score for all diagnoses was gW.i, when compared to eb.a for the general 
population, with higher values meaning lower OHRQoL.   
Of the various TMD conditions, disc displacement with reduction has the 
least effect on the OHRQoL (John et al., W^^]). Indeed, this condition is 
frequently pain-free, although joint sounds may be heard. Increasing levels 
of disability, i.e. higher Graded Chronic Pain Scale (GCPS) scores were 
associated with a decreased OHRQoL (John et al., W^^]). Barros et al. (W^^i) 
found that ia.]% of the patients referred for TMD treatment at a Brazilian 
University reported some negative impact of TMD while b]% reported that 
TMD pain and dysfunction impacted daily activities. Similar findings were 
reported by Murray et al. (eii`) who found in a cohort of new patients 
referred to a Canadian facial pain research unit that b^% could ignore the 
pain or carry on with daily activities despite pain, W]% reported that the pain 
interfered with their ability to concentrate, while the remaining WQ% found 
the pain to be debilitating, requiring them to undertake only simple tasks or 
take rest. These studies show that TMD pain may have a significant negative 
impact on the quality of life and the ability to perform daily activities. This 
is not surprising and reflects individual differences in coping with pain. 
1.4 AETIOLOGY OF TMD 
The aetiology of TMD has been the subject of many publications and many 
theories have been suggested in the past. A substantial step forwards in the 
understanding of TMD aetiology has been provided by the “Orofacial Pain: 
Prospective Evaluation and Risk Assessment” (OPPERA) study (Slade et al., 
W^eQb). This evaluated risk factors for the onset of TMD in W,]Q] participants 
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followed for Q years. This study clearly indicated that TMDs have a 
multifactorial aetiology, i.e.  that they are due to the interplay of different 
factors consistent with the biopsychosocial model of disease. Variables of the 
health status domain made the greatest contribution to TMD incidence, 
followed closely by psychological and clinical orofacial domains (Fillingim et 
al., W^ee). Genetic factors were also concurring. Interestingly, a previous 
epidemiological study reported similar risk factors for TMD onset already at 
early adolescence (LeResche et al., W^^]). The OPPERA study also showed 
that oral parafunction (e.g. clenching the teeth during wakefulness or 
holding the jaw rigid) was the single most significant predictor of TMD 
(Ohrbach et al. W^eg), confirming the results of previous studies consistently 
showing that self-reported tooth clenching are associated with myogenous 
TMD pain; (Gramling et al., eii]; Macfarlane et al., W^^e).  Of notes is the 
apparent low association between self-reported bruxism/wake-time 
parafunction and painful TMD (Van der Meulen et al., W^^`). Nevertheless, 
the risk of developing masticatory muscle pain is g-b times higher in 
individuals with the habit of keeping the teeth in contact during wake-time 
than in those without (Huang et al., W^^W; Michelotti et al., W^e^; Reissmann 
et al., W^e]).  
1.5 PARAFUNCTIONAL BEHAVIOUR 
Parafunctional oral behaviours are those behaviours not related with the 
“normal” function of the masticatory system. The most known parafunction 
is bruxism, which is defined as a repetitive jaw-muscle activity characterized 
by clenching or grinding of teeth and/or by bracing or thrusting of the 
mandible (Lobbezoo et al., W^eQ). The disorder may occur in sleep (sleep 
bruxism) and while awake (wake-time parafunction). It is important to 
differentiate sleep bruxism from wake-time parafunction. Sleep bruxism is 
related to sleep architecture and in particular to microarousal (Lavigne et al., 
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W^^Q; Macaluso et al., eiia), while wake-time parafunction is most likely a 
behaviour related to  psychosocial factors such as stress, anxiety and 
depression (Manfredini and Lobbezoo, W^^i; Khawaja, et al., W^ebb). Beside 
their different aetiology, sleep bruxism and wake-time parafunction differ 
also for the way muscles contract. Sleep bruxism is characterized by medium 
intensity contractions that on average last e^-eb sec (Kato et al., W^^e; 
Lavigne et al., W^^e)  while wake-time parafunction seems to be expressed by 
longer-lasting, low-intensity contractions (Fujisawa et al., W^eQ).  
1.5.1 ASSESSMENT AND EPIDEMIOLOGY 
Unlike sleep bruxism, there is little objective information on the prevalence 
of wake-time parafunction assessed in habitual environments in healthy 
subjects and TMD patients. Assessment of parafunctional activity uses 
questionnaires, ecological momentary assessment (both of which are 
subjective) and electromyographic recording of elevator muscles. The 
estimated prevalence of wake-time parafunction using a questionnaire varies 
between WW% and Qe% (Manfredini et al., W^eQ). Questionnaires are inevitably 
linked to recall bias, which may limit the validity of prevalence data collected 
in this manner. The Oral Behaviour Checklist (OBC) is a validated 
questionnaire used in many studies, including the OPPERA project, to assess 
for the presence of self-reported parafunctional habits (Markiewicz et al., 
W^^`; Ohrbach et al., W^^a). The OBC is a We-item questionnaire which 
yields a score ̂ -ag depending on the self-perceived frequency of various oral 
behaviours. 
Ecological momentary assessment (EMA) is a technique by which a subject 
is reminded several times over the study period to report the 
presence/absence of a behaviour – for instance, tooth contacts (Chen et al., 
W^^]; Glaros et al., W^e`; Bracci et al., W^ea). This approach allows subjects 
to recall the behaviour close to the time of its occurrence and 
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decreases/eliminates the recall bias. In the study by Chen et al. (W^^]), 
participants were alerted every W^ minutes during the day to check and 
report whether their teeth were in contact over e^ days. While this is a better 
alternative to retrospective self-reporting questionnaires, this study does not 
provide a detailed understanding of muscle activity throughout the day.  
The paucity of information on parafunctional activities when awake may be 
ascribed to practical difficulties of using portable EMG recorders, which may 
be wired and may interfere with common activities. The development of 
portable, wireless EMG devices allows for such behaviours to be assessed in 
a natural environment. 
Objective data on masticatory muscle activity (MMA) (frequency, intensity, 
duration) can be gained through the use of surface electromyography (EMG). 
EMG detects muscle activity and can provide accurate data on oral 
behaviours over an extended period of time. Perhaps due to the obtrusive 
nature of EMG equipment, most of the long-term studies have focused on 
night time masticatory muscle activity (Miguel et al., eiiW; Gallo et al., eiii). 
Raphael et al. (W^eQ) reported background masticatory muscle 
electromyographic activity was elevated during sleep in women with 
myogenous TMD pain. There is limited data on the association of objectively 
recorded masticatory muscle activity during wake-time in healthy subjects 
and myogenous TMD pain patients. This lack of information was the basis 
for this study. 
1.5.2 WAKE-TIME PARAFUNCTION AND TMD 
Knowledge on wake-time parafunction is limited in comparison to that on 
sleep bruxism. Both forms have been associated with a higher risk of TMD. 
More recent observations seem to favour the role of wake-time parafunction 
in the aetiology of TMD, although it is possible that in the aetiology cascade, 
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sleep bruxism and wake-time parafunction are not independently associated 
but interact additively, i.e. the presence of each one amplifies the effect of 
the other one (Reissmann et al., W^e]).  
The role of wake-time parafunction in the aetiology of masticatory muscle 
pain is biologically plausible. Indeed,  repetitive, long-lasting, low-level 
muscle contractions, as they likely occur also during wake-time parafunction 
in myogenous TMD patients, are a significant risk factor for work-related 
muscle pain (details in Palla (W^eg) and Palla and Farella (W^e^)). It is 
hypothesized that during these muscle contractions small (Cinderella) 
motor units become fatigued and damaged leading, in turn, to a localized 
inflammation with release of inflammatory mediators (Hägg, eiie). These 
sensitize the muscle nociceptors (Furquim et al., W^eb). 
In healthy individuals these changes usually resolve and are not able to 
trigger longer lasting and self-perpetuating masticatory muscle pain 
(Takeuchi et al., W^eb), although opposite results were reported by Glaros 
and Burton (W^^g). Independently of these seemingly contradictory results, 
wake-time parafunction alone is not a sufficient cause to trigger a clinical 
condition. Whether it will lead to muscle overuse and persistent pain likely 
depends upon the interplay of local (the frequency of long-lasting muscle 
contractions, the capacity for motor units substitution or rotation, the 
flexibility in spatial muscle activation and the adaptation capacity of the 
muscle tissue), genetic and psychosocial factors (fear-avoidance beliefs, 
somatization, anxiety and catastrophizing) (Palla, W^eg), that are involved in 
the individual adaptation/modulation of pain conditions as reported by the 
OPPERA study (Slade et al. W^eQb).   
That wake-time parafunction can be considered a risk factor for myogenous 
TMD is supported also by the observation that prolonged submaximal 
muscle contractions are observed in TMD patients. For instance, Glaros et 
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al. (W^^b) reported more frequent tooth contact and a higher intensity of 
contact in patients with TMD-related pain than in pain-free subjects. 
Similarly, non-functional tooth contacts were nearly four times more 
frequent in patients with masticatory muscle pain than in controls (Chen et 
al., W^^]). Moreover, subjects with wake-time parafunction have a g-b times 
higher risk of developing masticatory muscle pain than individuals without 
it (Huang et al., W^^W; Michelotti et al., W^e^; Reissmann et al., W^e]). The 
fact that wake-time parafunctional activity does not differ between male and 
female could be considered evidence contradicting the involvement of this 
behaviour in the aetiology of TMD as more females than males suffer of 
painful TMD. However, this discrepancy could be explained by a higher 
susceptibility of females than males for muscle pain.  
Electromyographic recordings of muscle activity during waketime also 
indicate an association between painful TMD and masticatory muscle 
activity during waketime.  Cioffi et al. (W^e`) reported that female patients 
with masticatory myalgia had an increased frequency of wake-time muscle 
contractions compared to healthy females during mental and practical 
ability tasks. A series of daytime recordings using portable EMG recorders in 
which the activity of the masseter and temporal muscles were recorded in 
the natural environment during wake time reported an overall longer 
contraction time in patients with TMD (with or without pain) than in 
controls. The largest difference was found to be for low-intensity 
contractions that lasted on average bi and W^ minutes in patients with and 
without disc displacement, respectively (Iwasaki et al., W^eb; Iwasaki et al., 
W^e]; Khawaja et al., W^eba). Shorter average duration was recorded in 
another study (Iwasaki et al., W^eb). Also in subjects with self-reported 
daytime clenching, the largest number of contractions episodes are of low-
intensity (Fujisawa et al., W^eQ). It must however be underlined that 
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association does not mean causality. To indicate a cause-effect relationship 
the association must fulfil several conditions as reported by Hill (ei`b).  
1.6 STUDY OBJECTIVES  
Due to the paucity of EMG recordings of the elevator muscles during wake-
time in the natural environment, in particular in patients with myogenous 
TMDs, the aim of this study was to record the electromyographic activity of 
a masseter muscle during wake-time in the natural environment in a group 
of healthy individuals and patients with myogenous TMD matched for age 
and gender. A secondary aim of this study was to investigate the association 
between self-reported oral parafunction and masticatory muscle activity. 
Specifically, the goal was to investigate whether there is a difference in the 
frequency, duration and magnitude of masseter muscle contractions 
between the two groups and whether the level of activity was correlated to 
the OBC summary score.  
The tested hypothesis was that myogenous TMD patients contract the 
muscles for a longer period of time, in particular that they have a greater 
frequency of long-lasting, low-amplitude contraction episodes than healthy 
individuals, and that participants with a higher OBC summary score have a 
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2.1 STUDY DESIGN 
 
An observational case-control study was designed according to the STROBE 
guidelines (Elm et al., W^^]).  
2.2 SETTING 
This study was conducted at the University of Otago, Dunedin. Participants 
were recruited and data were collected between August W^e] and June W^ea.  
2.3 PARTICIPANTS 
2.3.1 SAMPLE SIZE AND POWER 
The required sample size was estimated using previous data on mean 
duration of masticatory contraction episodes per day (W.] ± e.^ sec; 
Michelotti et al., W^^b). Setting type I error to ^.^b and type II error at ^.W 
(i.e. a^% power), a sample of Q^ participants per group would allow 
detection of a small-to-medium effect size (Cohen’s d ≤ ^.]).  
2.3.2 PARTICIPANT RECRUITMENT AND SELECTION CRITERIA 
Participants were recruited for the study by: e) contacting patients on the 
Faculty of Dentistry TMD waiting list; W) e-mail advertising distributed to 
University of Otago and Otago Polytechnic staff and students; Q) a number 
of advertisements on the ‘Otago University Postgraduate Society’ Facebook 
page; g) fliers placed around the University of Otago campus and: b) word of 
mouth. 
Inclusion criteria were female patients in the age range ea-b^ years with a 
painful myogenous TMD. The control group included individuals without a 
past or present history of TMD and headache (in the month preceding the 
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examination) and on examination, free of signs of TMD except for a pain-
free disc displacement with reduction. 
Both patients and control individuals were excluded from the study if they 
were: undergoing orthodontic treatment with fixed appliances; missing five 
or more permanent teeth (excluding third molars); using full fixed or 
removable dental prostheses; had any present orofacial inflammatory 
conditions; rheumatological conditions; neurological disorders and/or 
neurological motor disorders; acute psychiatric conditions; primary 
headache form; craniofacial syndromes including cleft lip and/or palate; 
were habitual users of drugs influencing the activity of the central nervous 
system (CNS), and; if they self-reported any skin allergy to plaster adhesive. 
As TMD predominantly affects females, only females were included to avoid 
variability due to gender. The age range selected was broad enough to 
include prevalence peaks of TMD between W^-g^years (Leresche and 
Drangsholt, W^^a). The upper limit was set at b^ years because an increased 
prevalence of inflammatory-degenerative joint disorders could be expected 
above this age (Manfredini et al., W^e^).  
Participants undergoing orthodontic treatment were excluded because of 
the known reduction in maximal bite force during fixed appliance treatment 
(Alomari and Alhaija, W^eW). Participants with more than b missing teeth 
were excluded due to the association between decreased occlusal contacts 
and bite force (Bakke, W^^`).  Maximal bite force is significantly greater in 
dentate subjects than in denture wearers and therefore, participants with 
removable or fixed dentures were excluded (Haraldson et al., ei]i). 
Participants with orofacial inflammatory, rheumatologic disorders and 
primary headache form were excluded so not to confound TMD diagnosis. 
Participants with neurologic conditions and neuromotor disorders were 
excluded due to a possible effect on central pain processing and muscle 
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regulation. Those with acute psychiatric conditions and habitual users of 
drugs, such muscle relaxants and sedatives, were excluded because of their 
effect on the central nervous system. Finally, participants with self-reported 
allergies to plaster adhesive were excluded due to the exposure of such 
adhesives during the EMG stage of the study. 
All participants provided informed written consent prior to participation in 
the study and received a $b^ supermarket voucher upon completion of the 
study.  
2.4 STUDY PROCEDURE 
This study consisted of three phases: screening, clinical examination and 
EMG data collection. 
2.4.1 SCREENING 
First contact with participants from the TMD waitlist was by phone call 
followed by e-mail. The first contact with all other participants was by e-
mail. Participants were sent a Participant Information Sheet and asked to 
complete an electronic form (Google® Form) which included the 
demographics questionnaire, the DC-TMD Symptom Questionnaire and the 
Graded Chronic Pain Scale vW.^ (Von Korff et al., eiiW; Schiffman et al., 
W^eg). The responses to electronic forms were screened prior to 
appointments being scheduled. Patients were recruited first and controls 
were age-matched +/- Qyrs to the patients and recruited. 
2.4.2 CLINICAL EXAMINATION 
At initial appointment, informed written consent was obtained from the 
study participants. A thorough history was collected including initial onset, 
location, characteristics, severity, triggers, frequency and duration of pain.  
A single investigator (DR) performed a standardised clinical examination to 
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clinically evaluate and assess eligibility of participants for inclusion in the 
study.  
The clinical examination included recording of maximum (pain free, assisted 
and unassisted) mouth opening, maximum lateral and protrusive excursions. 
Familiar pain (pain that is like or similar to the pain the patient has been 
experiencing) during these tasks was noted. Joint noises (clicking or 
crepitation) during opening and closing, lateral and protrusive excursions 
were checked and recorded if present. The temporal and masseter muscles, 
TMJs and supplemental muscles were palpated and associated pain 
recorded, including if the pain was localised or referred. Digital pressure for 
clinical examination was not calibrated. 
Patients were those diagnosed with masticatory muscle pain, which included 
“myofascial pain” and “myofascial pain with referral”. For the purpose of this 
study, the group “myofascial pain” also included the diagnosis “local myalgia” 
following the DC-TMD guidelines for diagnosis (see Appendix ̀ .i, Schiffman 
et al., W^eg, Ohrbach et al. W^eg),.  
Participants with no TMD-related pain were eligible as controls. That is, they 
needed to confirm lack of TMD pain or headaches in the past month, and 
absence of TMD signs on clinical examination. 
Approximately W^ individuals who received the Participant Information 
Sheet either did not respond, indicated they did not want to participate, or 
were unavailable to participate in the study. Some b individuals indicated 
interest in the study but missed their clinical examination appointment and 
were not followed up. Of the individuals examined, g were not included in 
the study: W were not eligible for the control group due to headaches or 
migraines, and W were not eligible for pain group due to the lack of 
myogenous TMD diagnosis (had arthrogenous conditions only). 
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2.4.3 EMG DATA COLLECTION 
2.4.3.1 EMG EQUIPMENT 
Wireless EMG device 
A small wireless EMG device developed at the University of Otago was used 
for this study. The device was small and minimally invasive, weighing g.e g 
and measuring WaxQb mm (Figure W.e). The device housed a printed circuit 
board (PCB) which electrically connected all the device components and was 
powered by a disposable QV lithium battery (CRW^QW, Energizer, Town and 
Country, Missouri). EMG activity was sampled at e^^^ Hz using a 
programmable gain right leg drive amplifier (ADSeWie, Texas Instruments, 
Dallas, Texas), low-pass filtered using a cut-off frequency of gQW Hz 
(antialiasing filter) and AD converted with a Wg-bit resolution. The data were 
down sampled to a Hz by computing root mean square (RMS) power in non-
overlapping eWbms rectangular windows. The RMS data (Wg bit) were then 
wirelessly transmitted in packets of four data every b^^ ms to a dedicated 
android based smart phone via the Bluetooth Low Energy (BLE) protocol. 
 
 




Custom-made disposable Ag/AgCl surface electrodes (SPES Medica, Genova, 
Italy) were used in the study. The electrodes were arranged in a triangular 
configuration with distance of W^mm between the active electrodes. The 
right leg drive (RLD) was at a distance of WQ.bmm to the active electrodes. 
The electrodes had snap connectors that allowed connection to the wireless 
EMG device.  
Smartphone application 
An Android smartphone application (app) called EMG Guard™ was 
developed for visualisation, calibration and logging of EMG activity. The 
recorded data was transmitted to a smartphone via Bluetooth or ANT+. The 
app was designed to be user-friendly and allowed the investigator to set 
threshold values for detection of contraction episodes (see below) prior to 
the start of the recording session. The EMG data received from the device 
was stored in the internal memory of the smartphone. 
Accelerometer 
An accelerometer (GENEActiv, Activinsights, Kimbolton, UK) was used to 
collect body activity data, however the results from this are not presented in 
this thesis. 
2.4.3.2 EMG PROTOCOL 
Following confirmation of eligibility in either group, participants were able 
to choose to commence EMG data collection on the same day or reschedule 
to another day within two weeks if this was more convenient to them. The 
EMG activity during wake-time was recorded on two consecutive days. 
The device was fitted on the participants’ preferred chewing side. For 
participants lacking a preferred side, the right-hand side was selected.  
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Prior to placement of the device, the skin surface was prepared with an 
abrasive gel (Nūprep™, Weaver and Company, Aurora, CO, USA) to lower 
skin impedance at the electrode site. The gel was scrubbed on the skin 
overlying the masseter for approximately one minute by the participant. The 
gel was removed from the skin surface with medical grade gauze. Thereafter, 
the skin was further cleaned with an isopropyl alcohol swab.  
The masseter muscle was palpated to determine position and orientation of 
the electrodes. The EMG device was placed so the active electrodes were 
along the masseter long axis, and the RLD electrode pointing back towards 
the ear (see Figure W.W). Once positioned on the skin surface, the EMG device 
was linked to the smartphone via the app and recording was commenced 
(Figure W.Q a-d). 
 




showing connection via Bluetooth or ANT+ (a), beginning an EMG recording (b), 
the dashboard view showing live RMS detected (c), calibration mode in which the 
peak prolonged contraction was selected as MVC (d), User Mode used by 
participant, shows real time visualisation of EMG signal detected and buttons to 
log activity (e), exit user mode to save and stop recording (f). 
Figure B.G a-f - EMG Guard Android smartphone application screenshots  
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First, the maximum voluntary clenching (MVC) and EMG activity at rest, 
while keeping the teeth slightly in contact, were recorded. To register the 
EMG at MVC participants were asked to perform three to five maximal 
clenches with an aligner tray seater (Chewies™, Dentsply, York, PA, USA), 
placed between the posterior teeth on the same side as the sensor. MVC were 
separated by rest intervals of approximately eb seconds (Figure W.Qa-d). The 
peak EMG activity, excluding obvious outliers that varied by more than Q^%, 
produced during maximal voluntary contraction (MVC) was selected. To 
record the EMG level at rest, participants were asked to allow their face 
muscles to relax completely with their teeth apart for approximately W^ 
seconds.  
Thereafter, participants were instructed in the use of the smartphone, of the 
app and how to stop and save the recording (Figure W.Q e-f). Safe removal of 
the device from the skin surface and storage in a sealed container was also 
carefully explained. 
Participants were asked to wear and leave the EMG device on for 
approximately eW hours, during daytime. They were also asked to log 
activities on the app such as eating, sleeping, and ‘other’ user-defined activity 
such as running, cycling or strenuous exercise, and not to actively alter 
behaviours (such as eating or exercise) during the period of EMG recording. 
Care was taken to avoid any verbal instructions to the participants that 
would sensitise them or alter oral behaviours during the recording. 
Participants returned the following morning and the whole process was 
repeated and the device recalibrated.  
Following the second recording day, participants were asked to complete the 
Oral Behaviour Checklist on Google Forms™ (Markiewicz et al., W^^`; 
Ohrbach et al., W^^a). This questionnaire was provided at the end of EMG  
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recording in order to minimise the risk of bias by sensitising the participants 
to these behaviours.  
2.4.4 TREATMENT AND FOLLOW UP OF PATIENTS 
After participating in the study, TMD patients were internally referred to the 
Discipline of Oral Medicine for ongoing treatment and care.  
2.5 DATA ANALYSIS 
2.5.1 QUESTIONNAIRE AND CLINICAL EXAMINATION DATA  
GCPS and OBC questionnaire data was scored as per DC-TMD Scoring 
Manual for Self-Report Instruments (Ohrbach and Knibbe, W^e]).  
2.5.2 CONTRACTION EPISODES 
The EMG data recordings were downloaded from the smartphones. These 
recordings were plotted using a script in R™ software (vQ.Q.e, R Foundation 
for Statistical Computing, Vienna, Austria) and were used in subsequent 
analysis for quality check of recordings. 
Raw EMG data from the device were imported into MatLab_RW^e`b 
(MathWorks, Natick, Massachusetts, USA) for computation of contraction 
episodes statistics. A contraction episode was defined as a signal above a 
defined threshold which could contain sub-threshold signal portions shorter 
than a stand-by time to of b sec (Gallo et al., eiii; Farella et al., W^^b). The 
number, amplitude and duration of contraction episodes detected by the 
EMG device were calculated as previously described (McNee et al., W^eQ) 
using a threshold of Qx “minimum at rest”, Q% MVC, b% MVC and e^% MVC.  
‘Minimum at rest’ was defined as the lowest root mean square (RMS) value 
during a e^sec ‘rest’ period. Thrice the minimum at rest was found to be 
indicative of a low-level clench.  
 30 
The number of contraction episodes per hour (ep/hour) was calculated at 
each threshold. Total contraction time was defined as the sum of the 
duration of all contraction episodes above a defined threshold (e.g. Q% 
MVC). Relative contraction time was defined as the total contraction time 
divided by the total recording time and was reported as a percentage.  
2.6 STATISTICAL ANALYSIS 
Statistical analyses were performed using SPSS (version W^.^, IBM 
Corporation, Chicago, Illinois, USA).  
Data were firstly analysed with conventional descriptive statistics. If not 
specified otherwise, variability was expressed as a standard error of the mean 
(± SEM). Data were then analysed using a linear mixed model. This analysis 
was used to investigate whether features of contraction episodes differed 
between patients and controls. The mixed model response variables were 
“Episode per hours”, and “Relative Contraction Time”. The variables “day”, 
and “group” were entered as fixed factors, while the variable “individual” was 
entered as random term. Multiple analyses were run for contraction episodes 
assessed for the four different thresholds. Where appropriate, Bonferroni 
corrected post-hoc multiple comparisons were run. The significance level 
was set at ^.^b. 
2.7 DATA STORAGE 
2.7.1 STORAGE OF QUESTIONNAIRES AND EXAMINATION FORMS 
Hard copy consent and examination forms were kept in secure storage 
within the Faculty of Dentistry, University of Otago. These questionnaires 
will be retained for up to e^ years at the above location. The electronic forms 
completed by the participants were stored on the Google Drive cloud server. 
These forms will be saved on the secure cloud server for up to e^ years. Only 
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the investigators involved in this study were able to access these 
questionnaires.  
2.7.2 STORAGE OF EMG DATA 
EMG data files were downloaded from smartphone internal storage and were 
stored on a secure hard drive within the Faculty of Dentistry, University of 
Otago. These may be accessed by the investigators for follow up on this 
study. 
2.8 FUNDING 
The study was supported by the New Zealand Dental Association Research 
Foundation (RF a.^a W^e`). 
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Energizer New Zealand donated W^^ CRW^QW batteries for use in this study. 
2.9 ETHICAL APPROVAL 
This study was approved by the University of Otago Ethics Committee in 
December W^e` (reference He`/eWb) – see Appendix `.e.  
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Aims: The aim of the present study was to describe the features of 
temporomandibular (TMD) signs in females with myogenous orofacial pain, 
and to investigate whether the level of self-reported parafunctional 
behaviours differed between females with myogenous TMD pain and healthy 
controls.    
Methods: Females students and staff members from the University of Otago 
and Otago Polytechnic were recruited by e-mail and social media advertising 
as well as paper flyers placed around campus. Patients were also recruited 
from the Faculty of Dentistry TMD waitlist. DC-TMD Symptom 
Questionnaire, Graded Chronic Pain Scale (GCPS) and Oral Behaviour 
Checklist (OBC) were completed online using Google Forms™. A 
standardised examination was conducted by a single investigator and 
patients allocated to a myogenous pain or pain-free group. 
Results: Myofascial pain without referral was the most common diagnosis 
affecting ai.]% of the patients. Myofascial pain with referral was found in 
the remaining e^.Q%. Of the patients with myofascial pain, ae.b% reported 
familiar pain in the masseter and temporal muscles on palpation while the 
remaining patients reported familiar pain only in the masseter muscle. A 
joint click was detected in Q].^% of the patients compared to ].]% in the 
controls (p < ^.^^e). Maximum unassisted and assisted opening was 
significantly higher in controls (bg.^ ± `.gmm and bb.b ± `.Wmm) than 
patients (g`.i ± `.gmm and be.^ ± b.^mm) (p < ^.^e). Patients self-reported 
a higher frequency or number of oral behaviours with the average OBC 
summary score differing with statistical significance (Qe.^ ± a.] vs. We.] ± e^.a, 
p = ^.^^e). The GCPS score was e.`] ± ^.]Q in patients and ^.eW ± ^.QQ in 
controls. 
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Conclusion: Females with myogenous orofacial pain had distinct clinical 
features consisting of muscle tenderness to palpation, limited jaw function 
and joint sounds. In addition, they had significantly higher level of self-
reported wake-time parafunctions.  
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3.2 INTRODUCTION 
Temporomandibular disorder (TMD) is a term that encompasses a range of 
conditions affecting the masticatory muscles and/or the temporomandibular 
joint (TMJ) (Liu and Steinkeler, W^eQ). TMD is commonly characterised by 
pain, joint sounds and altered function (Dworkin and LeResche, eiiW) and 
most commonly affects females with a peak occurrence between W^ and g^ 
years of age (Leresche and Drangsholt, W^^a). The “Orofacial Pain: 
Prospective Evaluation and Risk Assessment” (OPPERA) study (Slade et al., 
W^eQ) provides strong evidence that TMDs have a multifactorial aetiology, 
i.e. that they are due to the interplay of different factors consistent with the 
biopsychosocial model of disease. Variables of the health status domain 
made the greatest contribution to TMD incidence, followed closely by 
psychological and clinical orofacial domains (Fillingim et al., W^ee). Genetic 
factors were also concurring. 
The OPPERA study also showed that parafunction was the single most 
significant predictor of TMD (Ohrbach et al. W^eg). Parafunctional 
behaviours are activities conducted during the day such as clenching, 
grinding, nail/lip/cheek biting – all of which fall outside the normal 
physiological functioning of the stomatognathic system (Ohrbach et al., 
W^^a). These parafunctional oral behaviours have the potential of 
overloading muscles and joints (Winocur et al., W^^`). An association 
between parafunctional behaviour and TMD has been reported in several 
studies as reported in Chapter e.g “Aetiology of TMD”. However, an 
association is not proof of causality.  The pain reduction upon habit reversal 
therapy, such as reduction of tooth contacts, seems to support this 
association too, (Glaros et al., W^^]), although pain remission can occur for 
several reasons (Palla et al., W^eg).  
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Oral parafunctions are measured using questionnaires, Ecological 
Momentary Assessment or electromyography. A commonly used 
questionnaire is the Oral Behaviour Checklist (OBC) which has been 
proposed as an instrument to measure self-reported parafunctional 
behaviours (Markiewicz et al., W^^`; Ohrbach et al., W^^a).   
3.3 STUDY AIMS 
The aim of this study was to e) describe the features of temporomandibular 
(TMD) signs of females with myogenous orofacial pain, and W) and to 
investigate whether the level of self-reported parafunctional behaviours 
differed between females with myogenous TMD orofacial pain and matched 
healthy controls.    
3.4 MATERIALS AND METHODS 
Comprehensive details of methodology relating to participant recruitment, 
questionnaires, clinical examination and data analysis are presented in 
Chapter W – Core Methods and Materials. 
A total of `b participants expressed interest in the study. Of these, ba were 
clinically examined and b were found to be ineligible based on the inclusion 
and exclusion criteria. The final study sample comprised bQ female subjects 
in total. This included W] women suffering from masticatory muscle pain and 
W` controls who were matched for age and gender to the patient group. 
3.5 RESULTS 
3.5.1 DEMOGRAPHIC CHARACTERISTICS 
The demographic data of all participants is presented in Table Q.e 
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Table G.:  - Characteristics of the studied groups 
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All combined W] W` 
a χW test: p = ^.^^e 




Patients (W].^ ± `.Q years) and controls (Wa.^ ± `.b years) did not differ 
significantly for age (p = ^.ab`) and marital status (p = ^.ge`). However, the 
two groups were not matched for ethnicity (p = ^.^^e). New Zealand 
European constituted the majority of the patient group. Asian ethnicities 
(including Indian, Chinese, Japanese and Korean) made up ee% of the 
patients and gW% of the controls.  
The majority of participants in both groups were undergraduate or 
postgraduate university or polytechnic students. Five patients were not 
affiliated with the university/polytechnic and were recruited from the TMD 
waiting list at the Faculty of Dentistry at the University of Otago. E-mail 
advertising was effective in recruiting over two thirds of the participants for 
both groups. Word of mouth was effective for the recruitment of almost a 
quarter of the control group and the participants recruited by this method 
heard about the study from friends who had participated in the study. 
3.5.2 CLINICAL EXAMINATION FINDINGS 
Of the Q^ individuals examined for inclusion in the pain group, W] could be 
recruited. Two were excluded as they were found to have pain not related to 
the masticatory muscles: one had arthralgia only and the other a primary 
headache form. The third one was excluded as she had no previous history 
of jaw pain but was experiencing an acute flare up due to occlusal 
dysesthesia.  
Wa individuals were assessed for inclusion in the control group but W were 
excluded due to regular headaches within the month preceding the study. 
None of the W` controls had any TMD-related pain on clinical examination. 
As mentioned in chapter W.g.W “Clinical Examination”, ‘localised myalgia’ and 
‘Myofascial pain without referral’ were not differentiated in the clinical exam 
and are collectively termed ‘myofascial pain’ for the purpose of this study.  
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In Wg (aa.a%) of the patients, palpation caused a pain localized within the 
palpated muscle (myofascial pain) and in the remaining Q (ee.e%) the pain 
spread beyond the boundary of the muscle (myofascial pain with referral). 
Some WQ (ab.W%) of the pain patients reported familiar pain on palpation in 
the masseter and temporal muscles, while the remaining g (eg.a%) 
individuals only in the masseter muscle. 
 Joint noises were detected during clinical examination in eW patients (e^ with 
clicks, of which W had intermittent locking, and W with crepitus) and b 
controls (W with clicks, Q with crepitus). More patients self-reported TMJ 
noises in the DC-TMD Symptom Questionnaire than controls: WQ patients 
and b controls had self-reported joint noise(s) in the past month (χW test; p < 
^.^^e).  
The average maximum pain-free opening was Qa.g ± ].emm in patients, and 
eb (bb.`%) of these had limited pain-free mouthing (<g^mm). The average 
maximum unassisted and assisted mouth opening was significantly greater 
in controls than in patients (p ≥ ^.^^b) – Figure Q.e. Eight (Q^.a%) of the 
controls reported discomfort on maximum unassisted opening. However, 
they reported that this was not painful nor a familiar sensation, as they 
normally did not open that wide. 
 




























3.5.3 GRADED CHRONIC PAIN SCALE AND ORAL BEHAVIOURS 
CHECKLIST 
Participants completed the GCPS online up to a weeks prior to the clinical 
examination. Patients had an average characteristic pain intensity (CPI) 
score of gi.e ± eb.i and those of the control group of Q.W ± e^.]. The 
interference score (IS) was Q^.` ± WQ.g for the pain group and ^.` ± Q.Q for 
the control group. The overall CGPS was e.] ± ^.] for the pain group and ^.e 
± ^.Q for the control group. The distribution of CGPS scores of the groups is 
shown in Table Q.W. 
Table G.B – GCPS scores for patients and controls 



















All combined W] W` 
 
The OBC summary score was significantly higher for the pain group than for 
the control group (Qe.^ ± a.] and We.] ± e^.a respectively; p = ^.^^e) (patients 
N = W`, controls N = W`, Figure Q.W). One participant from the pain group did 





Figure G.B – Comparison of OBC summary scores between the patients and controls. 
 
The frequency distributions of the self-reported oral behaviours during 
waking hours is presented in Table Q.Q and Figure Q.Q In the table, the OBC 
Summary Score is dichotomised into low (e-Wg) and high (Wb-ag). The 
frequency distribution of “high” and “low” scores differed significantly 
between groups (p = ^.^^b), with We out of the W` patients having an OBC 
summary score above Wg. Patients had a slightly higher mean score for most 
oral behaviours except for leaning with hand on jaw, eating between meals, 
singing and holding the telephone between the head and shoulders (OBC 
items eb, e], ei and We).  
Table G.G – Oral behaviour summary score 
 Pain Group (%) Control Group (%) 









All combined W` W` 




Figure (.( – Self-reported oral behaviours during waking hours in patients and controls.  Data were compared by Mann-Whitney U Test; * p ≤D.DE; 






































































































































As expected, patients had some distinct features including masticatory 
muscle pain on palpation and a limited range of jaw function when compared 
to age-matched controls. In addition, jaw sounds (clicking and crepitation) 
were more common in the pain group.  
The OBC is an instrument that has been proposed in order to assess oral 
parafunction (Markiewicz et al., FGGH; Ohrbach et al., FGGJ). Patients 
reported a higher OBC summary score than controls, indicating that during 
wake-time, they had a more pronounced parafunctional behaviour than 
healthy controls. The OBC summary scores reported by patients and controls 
in this study were comparable to those reported by Cioffi et al. (FGMH) for 
females with myogenous TMD and healthy controls. The OPPERA study 
found that only an OBC summary score of FQ or more was associated with 
predicting the risk of first onset of TMD pain (Ohrbach et al., FGMM). In the 
present study, FM out of the FH pain patients who completed the OBC had a 
score in this range. Interestingly, MG out of the FH controls had an OBC 
summary score of FQ or more. This relatively high proportion of healthy 
controls with a high OBC score may be due to the relatively high proportion 
of students in the group. Various studies have shown a concerning rate of  
stress, depression and anxiety in university students (Regehr et al., FGMS), 
and these disorders are associated with wake-time oral parafunction 
behaviours (Khawaja et al., FGMQ). Moreover, there is an established link 
between emotional stress and parafunctional behaviours (Ohrbach and 
Michelotti, FGMJ).  
Limitations of the study included the clinical examination by a single 
examiner, the convenience sampling of the study group and the time lag 
between the completion of the Symptoms Questionnaire and Graded 
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Chronic Pain Scale and the clinical examination. While a clinical 
examination performed by a single examiner may warrant that the 
examination is conducted in all subjects in the same manner it also increases 
the risk of bias in the selection process. 
It is known that non-chronic myogenous TMD pain may resolve 
spontaneously. The majority of the pain patients had a GCPS score of I or II, 
that is, they had a low disability (only Z of the F[ patients were found to have 
a GCPS score of III and none had a score of IV). Therefore, it cannot be 
excluded that the characteristic pain intensity recorded when the patient 
filled the GCPS did not correspond to the value at the beginning of the study, 
due to the time lag between the filling of the GCPS and the clinical 
examination/the beginning of the EMG recording (as much as eight weeks, 
although usually two weeks).  
Initially, the patients were planned to be recruited solely from the Faculty of 
Dentistry TMD waiting list. However, due to a lack of interest from patients 
on the waiting list (that had been referred for TMD management by their 
general medical practitioners or family dentists) the net was cast wider. E-
mail advertising was found to be the most effective means of advertising for 
both groups. As a convenience sample was used, the results of this study 
cannot be extrapolated to the myogenous TMD pain “population” at large. 
This sampling method may also be responsible for the relatively low pain 
intensity reported by the patients, although the mean CPI score of patients 
in this study was comparable to that reported by Cioffi et al. (FGMH) for female 
with myogenous TMD.  
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3.7 CONCLUSION 
Females with myogenous TMD had a greater OBC summary score than 
healthy matched controls, indicating a higher degree of wake-time 
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Aims: The aim of the present study was M) to collect objective data on 
masticatory muscle activity during wake-time in the habitual environment 
in females with myogenous temporomandibular disorder (TMD) and age-
matched pain-free controls, F) to compare the features of masticatory muscle 
activity between the two groups, and S) investigate the association between 
self-reported oral parafunction and masticatory muscle activity. 
Methods: Female participants (N = F[, mean age F[.G ± H.S years) diagnosed 
with myofascial pain with and without pain referral were age and gender 
matched with controls free of TMD-pain (N = FH, mean age FJ.G ± H.Q years). 
A single examiner completed a standardised TMD examination on all 
participants, to confirm eligibility for the study. Participants wore a 
minimally invasive, wireless EMG device attached to the skin overlying the 
masseter muscle. Participants wore the EMG sensors whilst awake, over two 
consecutive days. Maximum voluntary contraction (MVC) was identified as 
peak bite force. Contraction episodes over Q seconds duration were detected 
at four thresholds: Sx minimum EMG activity at rest, S% MVC, Q% MVC, MG% 
MVC. The frequency, duration and amplitude of masseter contraction 
episodes were calculated and compared between the two groups by means 
of mixed model analysis. 
Results: MVC was MMFZ.[ ± QQG.JμV in the pain group and MFGF.Q ± ZFZ.QμV 
in the control group (p = G.QQf). Most masseter contraction episodes of both 
patients and controls were of relatively low amplitude (< MG% MVC) and 
short duration (<MG seconds). There was no significant difference in the 
number of episodes per hour between groups (p > G.GQ). A significant 
difference in total contraction time was found between groups (p = G.GSf) 
with a tendency to longer contractions in the pain patients. There was a 
significant interaction between the factors “group” and “threshold” (p = 
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G.GGH), suggesting that the difference of relative contraction time varied 
across thresholds, being more pronounced for low-level activity. No 
significant association was found between the level of self-reported 
parafunction and both the number of contraction episodes per hour or the 
relative contraction time. 
Conclusion:  Patients with myogenous TMD pain have a similar number of 
masseter muscle contractions during wake-time as age-matched pain-free 
controls but the contractions are longer in the myogenous TMD patients. 
Masseter muscle contractions are not significantly associated with self-
reported levels of oral behaviours and parafunctions. 
4.2 INTRODUCTION 
Temporomandibular disorder (TMD) manifest by pain in the muscles of 
mastication and/or the temporomandibular joint (TMJ), joint noises, and/or 
limited range of functional jaw movements (Golstein, Mfff; Liu and 
Steinkeler, FGMS). Females are more frequently affected with, and are more 
likely to seek treatment for TMD than males (Lipton et al., MffS; Carlsson, 
Mfff; Poveda-Roda et al., FGG[). TMD-related pain is the primary symptom 
in those seeking treatment (Dworkin et al., MffG; John et al., FGG[). The 
prevalence of TMD symptoms reported in the literature is highly variable but 
a systematic review reported a prevalence of f.[% for masticatory muscle 
pain in the general population (Manfredini et al., FGMM). 
It is widely accepted that TMD has a multifactorial aetiology with an 
interplay of patient health, psychological, genetic and biomechanical 
(parafunction) factors (LeResche et al., FGG[; Fillingim et al., FGMM; Ohrbach 
et al., FGMZ). The “Orofacial Pain: Prospective Evaluation and Risk 
Assessment” (OPPERA) study (Slade et al., FGMS) has provided valuable 
insight into the aetiology of the condition. The OPPERA study showed that 
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self-reported oral parafunction was one of the strongest predictor of TMD 
(Ohrbach et al., FGMZ). Parafunctional behaviours such as tooth grinding and 
tooth clenching habits are clinically associated with masticatory muscle 
tenderness (Okeson, MffH; Glaros and Burton, FGGZ; Winocur et al., FGGH; 
Chen et al., FGG[; Michelotti et al., FGMG; Ohrbach and Michelotti, FGMJ). The 
results presented in Chapter S show that patients with myogenous TMD pain 
have a higher level of self-reported parafunction compared to healthy 
controls. Wake-time parafunction differs from sleep bruxism and seems to 
be characterised by prolonged, low-level contractions (Fujisawa et al., FGMS). 
Most studies on wake-time parafunction rely on questionnaires and 
Ecological Momentary Assessment (EMA) (see chapter M.Q.M “Assessment and 
Epidemiology”). Questionnaires are invariably susceptible to recall bias 
which limits the validity of such data. EMA is a better alternative to 
questionnaires but still does not provide detailed understanding of muscle 
activity throughout the day.  
Objective data on masticatory muscle activity (MMA) can be obtained 
through the use of surface electromyography (EMG). EMG studies during 
wake-time are limited but have shown an association between painful-TMD 
and masticatory muscle activity.  Cioffi et al., (FGMH) reported female patients 
with masticatory muscle myalgia had an increased frequency of contractions 
compared to healthy females when performing standardised tasks. While a 
number of studies have assessed wake-time muscle activity in patients with 
various TMD conditions such as disc displacement (Iwasaki et al., FGMQ; 
Iwasaki et al., FGM[), myalgia/arthralgia (Khawaja et al., FGMQ), there is thus 
far limited data on the association between MMA while awake in myogenous 
TMD patients and healthy subjects. To date, the association between MMA 
(collected by EMG in the natural environment) and self-reported 
parafunction has not been investigated.   
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4.3 STUDY AIMS 
The aims of the present study were: M) to collect objective data on masticatory 
muscle activity during wake-time in the natural environment in females with 
myogenous TMD and age-matched pain-free controls, F) to compare the 
features of masticatory muscle activity between the two groups and S) 
investigate the relationship between self-reported oral parafunction and 
EMG activity. 
4.4 MATERIALS AND METHODS 
This study was approved by the Ethics Committee of the University of Otago, 
Dunedin, New Zealand. 
Methodological details pertaining to participant recruitment, 
questionnaires, clinical examination, electromyography, study procedure 
and analysis can be found in Chapter F - Core Material and Methods. 
4.5 RESULTS 
Masseter muscle activity was recorded for a total of HfH.H hours in the 
patient group and of HZZ.H hours in the control group, with a mean recording 
length of MF.Z hours per day in both groups (p > G.GQ) (Table Z.M). Some data 
was lost due to failure of the device connectivity to the smartphone via 
Bluetooth/ANT+. The percentage of missing data during recording was 
similar between patients and controls (H.S% and Q.M% respectively, p > G.GQ). 
The mean MVC was slightly lower in the patient group, but the difference 
between groups was not statistically significant (p > G.GQ). The minimum 





Table 6.8 – Characteristics of the EMG recordings averaged over the two recording days by 
study groups.  
 
Patients 
(mean ± SEM) 
Controls 
(mean ± SEM) 
F-value a p-value 
Recording time (hours/day) MF.Z ± M.S MF.Z ± M.H G.GM G.fSf 
Missing data (%) H.S ± H.F Q.M ± Q.H G.[Z G.SfQ 
Maximum voluntary 
contraction (μV) 
MMFZ.[ ± QQG.J MFGF.Q ± ZFZ.Q G.SQ G.QQf 
Minimum activity at rest (μV) MM.G ± G.H MM.M ± G.Q M.MG G.Fff 
Average activity at rest (μV) MS.Q ± G.H MS.H ± G.H G.FF G.HZQ 
a Results analysed using a mixed model analysis 
 
The mean number of contraction episodes of the masseter muscle varied 
with the thresholds used for episode detection. It ranged from around HGG 
episodes per recording day with a MG% threshold, to over M,MGG episode per 
recording day, with the lowest threshold (Sx minimum activity). Descriptive 
statistics for contraction episode counts is presented in Table Z.F. 
Table 6.9 – Episode count averaged over the two recording days in patients and controls.  
 
Patients 
(Mean ± SEM) 
Controls 
(Mean ± SEM) 
F-value a p-value 




MG% MVC  
 
MMF[.Z ± QH.H 
MGJ[.J ± HF.H 
fFZ.f ± QS.S 
HGJ.f ± Z[.F 
 
MMSF.S ± QJ.[ 
MMFS.H ± HZ.f 
JHf.F ± QQ.S 











a Mixed model analysis 
 
The distribution of all contraction episodes collected from all study group 
participants during the two recording days, according to their amplitude and 
duration is given in Figure Z.M. Episodes were mostly of low amplitude and 
short duration. The episodes are skewed by different thresholds. The 












Note that the proportion of longer episodes was slightly, but consistently higher in 





Figure (.* a-d – Relative proportion of masseter contraction episodes lasting longer than <, 

















































































The number of contraction episodes per hour was calculated for each 
threshold. The number of contraction episodes per hour was slightly higher 
in the patients at each of the tested thresholds but the difference was not 
significant (p > ?.?=). The number of episodes per hour by study group is 
presented in Figure F.@ and Table F.@. 
 
Figure (.. – Box plot showing the number of masseter contraction episodes per hour at 
various thresholds by study group. 
 
Table (.. – Masseter contraction episodes per hour at various thresholds by study group 
 
Patients 
(Mean ± SEM) 
Controls 
(Mean ± SEM) 






QQ.@ ± F.Q 
QF.? ± =.< 
R>.@ ± F.S 
=F.S ± F.@ 
 
QS.@ ± =.> 
Q=.T ± =.F 
TF.@ ± F.R 
FF.< ± F.F 
a All differences p > ?.?= 
 
A significant difference in relative contraction time was found between 
groups, with the myogenous TMD group having a longer contraction time 
than the control group (F = F.FT, p = ?.?@Q). There was a significant 








difference of relative contraction time varied across thresholds, and was 
more pronounced with lower detection thresholds (Figure F.F). Post hoc 
tests revealed that the differences between groups were most pronounced 
for episodes above @% MVC and =% MVC (F ≥ F.>Q, p ≤ ?.?=). For low 
detection thresholds (@x minimum, @% MVC, =% MVC), the difference in 
relative contraction time between groups ranged from F% to >?% with a 
smaller difference of only >% at the >?% MVC threshold (Table F.F).  
 








(Mean ± SEM) 
Controls 
(Mean ± SEM) 






<F.= ± >.R 
@<.? ± @.< 
>Q.S ± <.@ 
R.T ± ?.Q 
 
<>.? ± >.Q 
<<.> ± @.F 
>@.< ± <.F 
T.= ± ?.Q 









Regardless of their status (patient or control), all participants were grouped 
according to the reported level of oral parafunctions. Participants with a 
lower self-reported parafunction (OBC summary score ?-<F) had a similar 
number of contraction episodes per hour to those with a higher level of self-
reported parafunction (OBC summary score <=-RF) - Figure F.=.  
 
Figure (.2 – Number of episodes per hour by self-reported parafunction 
 
There was a trend to lower relative contraction time in participants with low 
self-reported parafunction but this difference was not statistically significant 


























































4.6  DISCUSSION 
This study aimed to compare masticatory muscle activity in females with 
myogenous TMD and healthy pain-free age-matched controls whilst awake 
and in the habitual environment, and to investigate the association between 
self-reported oral behaviours and EMG data.  
The EMG level at MVC and at rest position were not found to be significantly 
different between groups. The number of contraction episodes was similar 
in patients and controls, and episodes were mostly of short duration and low 
amplitude. Surprisingly, there was no significant difference in the number of 
contraction episodes between patients and controls. This finding contradicts 
results of Ecological Momentary Assessment studies that reported a higher 
frequency of tooth contacts and more muscle tension in TMD pain patients 
than in healthy controls (Chen et al., <??T; Glaros et al., <??=). This 
discrepancy is likely due to differences in the recording technique and in the 
study populations. Even if ecological momentary assessment reduces the risk 
of recall bias, only continuous EMG recording can detect when the masseter 
muscle contracts and, therefore, EMG recording should be regarded as the 
“gold standard” for assessing wake-time masseter activity.     
There was a significant difference in the relative contraction time with a 
longer relative contraction time in patients than controls, especially for 
contractions at low-intensity level. This finding supports the results by 
Khawaja et al. (<?>=) who also reported a longer contraction time (larger 
duty factor) in patients with TMD (with or without pain) than in controls. 
Unfortunately, the present study design does not allow us to answer 
questions on whether long-lasting masticatory muscle contractions are a 
cause of TMD or secondary phenomena of having TMD.  The “Cinderella 
hypothesis” (Hägg, >QQ>) postulates that type I muscle fibres (“Cinderella 
motor units”) can fatigue during prolonged low-level contractions, becoming 
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damaged, thus leading to local inflammation and subsequent nociceptor 
sensitisation and muscle pain. Palla and Farella (<?>?) reported the presence 
of Cinderella motor units in the masseter muscle during prolonged low-
amplitude clenching tasks performed at F-S% MVC. However, it remains to 
be demonstrated whether the duration of the low-level contractions 
recorded in this study could be sufficient to trigger a myogenous pain. 
Comparison with recordings from the trapezius muscles in patients with 
work-related trapezius myalgia suggest that much  longer low-intensity 
contractions episodes are associated with pain (Østensvik et al., <??Q; 
Hanvold et al., <?><; Hanvold et al., <?>@). It must, however, be emphasised 
once again that prolonged low-intensity contractions are not sufficient to 
lead to muscle pain and muscle pain is generally accepted as the result of the 
interplay of different factors (Palla, <?>F; Ohrbach and Michelotti, <?>R).   
No significant association was found between the OBC scores and the 
frequency of contraction episodes. The number of episodes per hour were 
similar in those (regardless of patient or control status) who self-reported a 
low level of parafunction and those who self-reported a high level of 
parafunction. There was tendency to a higher relative contraction time in 
those with a high OBC summary score, indicating longer contractions, but 
the difference was not statistically significant. Thus, the results of this study, 
which to our knowledge is the first in which the OBC was tested against 
continuous EMG recording of the masseter muscle activity, seem to not 
support the validity of the OBC. Some authors have advocated educating 
patients on what is meant by behaviours such clenching and grinding and 
repeating the self-reports after the patient has been asked to monitor their 
behaviours over a >- or <-week period for increased accuracy (Lobbezoo et al. 
<?>R).  
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Contrary to our expectation, MVC values did not differ significantly between 
patients and controls. Previous research has suggested that MVC is lower in 
TMD patients, and can be reduced by experimental induction of pain (Lund 
et al., >QQ>; Svensson et al., >QQR; Wang et al., <???). That MVC values were 
similar between groups in this study may be ascribed to the fact that patients 
had generally low-to-moderate pain levels (see below). 
The duration of recording was similar and comparable between days and 
groups. Two consecutive days of recording may have been insufficient to 
allow subjects to “forget” the recording device, i.e. it cannot be excluded that 
the individuals undergoing recording changed their habits, although they 
were instructed not to do so. Furthermore, despite care being taken to avoid 
verbal dialogue or instruction that sensitised the patient, a possible 
Hawthorne Effect cannot be excluded.  
This study has several shortcomings, the first one being the use of surface 
EMG which, in spite of likely being the best method to record the masseter 
muscle contraction behaviour in the habitual environment, is not free of 
limitations. Indeed, surface EMG recordings are less accurate than 
recordings with intramuscular fine-wire electrodes (Chapman et al., <?>?), 
because the intramuscularly recorded EMG signal is not contaminated by 
crosstalk from other muscles (Mangun et al., >QRS), which is the case with 
surface EMG devices especially when recording low-intensity contractions. 
During these recordings, the signal could have been contaminated by cross-
talk from other facial muscles (e.g. buccinator). In addition, analytical 
pattern recognition algorithms were not applied to differentiate between 
different oral behaviours. Thus, these shortcomings do not allow the 
conclusion that all contractions episodes corresponded to parafunctional 
activity. Further studies are necessary in order to assess which threshold level 
allows the best recognition of parafunctional activity. This evaluation would 
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likely require combined simultaneous registration of tooth contacts and 
EMG. Although physical activity data was collected, it was not analysed in 
this study. Periods of self-reported activity such as eating and physical 
activity were also not excluded or analysed separately. 
A further limitation of this study was the lack of bite force measurement such 
as that used by Iwasaki et al. (<?>=) for calibration of the EMG as an 
alternative to MVC, as such a measurement would circumvent the need for 
calculations reliant on MVC to determine the contraction episodes and 
relative contraction time.  
Maximum voluntary contraction is a measure routinely used for calibration 
in EMG studies. Though efforts were taken to standardise the collection of 
MVC in study participants, the MVC was found to be highly variable between 
individuals. This is not altogether surprising given the degree of individual 
variation in the size and form of the masseter muscle.  
Missing data is another limitation of this study. The use of a wireless EMG 
device introduced the need for a smartphone to act as a data recorder. The 
continuous recording of data relied on the smartphone being in range of the 
EMG device. Despite the instruction to carry the smartphone on their person 
or to remain within a @m radius of the smartphone, there were inevitably 
instances of the phone falling out of range of the EMG device. In such 
instances, the last outcome was carried forward. Any sequence of missing 
data greater than the threshold to detect a contraction episode (=sec) was 
discarded to minimise the effect of the missing data. Not only was the 
amount of missing data in this study relatively low (approximately =% of 
total recording time) but it was not different between the two groups. 
Therefore, it is safe to assume that this shortcoming has unlikely affected the 
results. 
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Another shortcoming relates to the fact that not enough patients and 
controls could be recruited to meet the target of @? participants per group 
to achieve R?% statistical power. Although the Faculty of Dentistry services 
the greater Otago area, with a population of just under a quarter of a million 
(Subnational population estimates: At @? June <?>T, Stats NZ), the number 
of successful recruits from the Faculty’s TMD waiting list was low. Due to the 
length of the waiting list, many participants reported spontaneous resolution 
of their symptoms since the referral was made. Perhaps due to the large 
student population and the transient nature of the TMD pain, many patients 
on the waiting list were no longer living in Dunedin or no longer affected by 
TMD pain when asked to participate in the study. Others were not interested 
in the study because they did not want to wear a device visible on their face. 
There was a significant difference in the ethnicity of participants between 
groups, though it is not known whether there is a difference in bite force or 
MMA between Asian and Caucasian populations. Because of the difficulty in 
recruiting participants for the pain group, we were unable to exclude mild 
patients (i.e. with low GCPS score). In fact, the pain group consisted almost 
entirely of patients with mild pain of limited disability and small impact on 
routine activities (see Chapter @). No information was collected on pain 
levels during the electromyographic recording. The final patient sample 
largely consisted of students that may not be representative of the general 
TMD pain population. Students also constituted the majority of the control 
group – of these, most were postgraduate students who were perhaps under 




Female patients with myogenous TMD pain had a similar number of 
masseter contraction episodes during wake-time as healthy subjects. 
However, the contraction episodes, especially those at low-intensity, lasted 
longer in the pain patients than in the controls. Self-reported oral 
parafunction, i.e. the OBC score, did not correlate with the number of 
contraction episodes, raising doubts about the validity of the OBC for 
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 FUTURE RESEARCH DIRECTIONS 
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This study used a wireless EMG device to record masseter muscle activity of 
myogenous TMD patients and healthy controls. We believe EMG is the gold 
standard for recording masticatory muscle activities as it does not suffer 
from the limitations of EMA approaches and self-report surveys of oral 
parafunctional behaviours. That the device is wireless means that 
participants can go about daily activities with minimal or no interference. 
In the future, the present study should be replicated using a larger sample 
and for a longer period of time. Future research should include patients with 
more severe and chronic TMD as well as healthier controls, such as the 
exclusion of joint noises or even distant past history of TMD. Future studies 
may also use pattern recognition algorithms to distinguish between oral 
behaviours. 
The use of the wireless recording and smartphone monitoring will facilitate 
large scale studies. An exciting opportunity exists whereby development of 
the smartphone app could allow participants to receive real time biofeedback 
in the form of a vibration of the phone to indicate muscle activity to raise 
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